Dr. Reddy’s and RDIF approved by DCGI to initiate Phase 2 trial for COVID-19 vaccine in India
Dr. Reddy’s and RDIF approved by DCGI to initiate Phase 2 trial for COVID-19 vaccine in India
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
DCGI's expert panel recommends Phase 3 clinical trial nod for Bharat Biotech's Covid-19 vaccine
Mid-Day
The expert panel at Central Drugs Standard Control Organisation (CDSCO) has recommended the top drugs regulator to grant permission..
-
Dr Reddy's gets DCGI go-ahead to conduct Phase 2/3 human trials of Sputnik V in India
IndiaTimes
-
Sputnik V Covid-19 vaccine gets nod for clinical trials in India
Mid-Day
-
Dr Reddy's gets DCGI nod for trial of Covid vaccine Sputnik V in India
IndiaTimes
-
Sputnik V Covid-19 vaccine made by Russia gets nod for clinical trials in India
Zee News
Advertisement
More coverage
Long Road Ahead To COVID-19 Immunity Even With Vaccines – OpEd
Eurasia Review
By Prabir Purkayastha*
As the pandemic continues to spread throughout the world, many countries seem to have given up..